Trump announces 100% tariff on generic drugs from August 2028, escalating to 200% in 2029

The announcement

President Donald Trump announced on Tuesday, July 21, that the United States will impose a new tariff schedule on imported generic drugs. Writing on his Truth Social platform, Trump laid out a phased approach that begins with a two-year duty-free window. The plan then escalates to a 100 percent levy, and later to 200 percent. The president described the tariffs as a tool to force pharmaceutical companies to move production back to American soil. No immediate reaction from industry groups or trading partners was available.

From August 1, 2026, all generic drugs imported into the United States will continue to benefit from zero percent tariffs for a period of two years, after which these tariffs will be raised to 100 percent for one year, then 200 percent thereafter.

Tariff timeline

The timeline is precise. Starting August 1, 2026, generic medicines will enter the US duty-free for 24 months. On August 1, 2028, the rate jumps to 100 percent. One year later, in August 2029, it doubles again to 200 percent. The White House did not immediately provide details on how the tariffs would be collected or whether any product categories might be exempted. The announcement did not mention any phase-in for active pharmaceutical ingredients versus finished dosage forms.

Reshoring goal

Trump explicitly tied the tariffs to a reshoring objective. He said the measure is intended to "reshore generic pharmaceutical production into the United States," penalizing companies that fail to build factories within the two-year grace period. The president added that existing tariff measures on other pharmaceutical products would remain unchanged. The April pharmaceutical tariffs, which can reach up to 100 percent, had excluded generics pending a review by the Commerce Secretary. That review was given a one-year deadline, and Tuesday's announcement appears to be its result.

This measure aims to reshore generic drug production in the United States, penalizing companies that decide not to build factories and facilities within the timeframe granted.

Existing pharmaceutical tariffs

In April, the administration imposed tariffs on a range of pharmaceutical imports, with rates as high as 100 percent. Generic drugs were explicitly carved out of that package. Trump directed his Commerce Secretary to study the generic drug market and recommend further action within one year. Tuesday's announcement, made via social media, did not reference that review directly but aligns with its timeline. The administration has not said whether the new generic drug tariffs will be layered on top of any existing duties or replace them.